The feasibility of a pragmatic randomised controlled trial to compare usual care with usual care plus individualised homeopathy, in children requiring secondary care for asthma
Received18 November 2010
revised09 May 2011
accepted09 May 2011
20 December 2017 (online)
Objective: To test the feasibility of a pragmatic trial design with economic evaluation and nested qualitative study, comparing usual care (UC) with UC plus individualised homeopathy, in children requiring secondary care for asthma. This included recruitment and retention, acceptability of outcome measures patients’ and health professionals’ views and experiences and a power calculation for a definitive trial.
Methods: In a pragmatic parallel group randomised controlled trial (RCT) design, children on step 2 or above of the British Thoracic Society Asthma Guidelines (BTG) were randomly allocated to UC or UC plus a five visit package of homeopathic care (HC). Outcome measures included the Juniper Asthma Control Questionnaire, Quality of Life Questionnaire and a resource use questionnaire. Qualitative interviews were used to gain families’ and health professionals’ views and experiences.
Results: 226 children were identified from hospital clinics and related patient databases. 67 showed an interest in participating, 39 children were randomised, 18 to HC and 21 to UC. Evidence in favour of adjunctive homeopathic treatment was lacking. Economic evaluation suggests that the cost of additional consultations was not offset by the reduced cost of homeopathic remedies and the lower use of primary care by children in the homeopathic group. Qualitative data gave insights into the differing perspectives of families and health care professionals within the research process.
Conclusions: A future study using this design is not feasible, further investigation of a potential role for homeopathy in asthma management might be better conducted in primary care with children with less severe asthma.
- 1 Ernst E. The truth about homeopathy. Br J Clin Pharmacol 2008 Feb; 65 (02) 163-164.
- 2 Shaw A., Noble A., Salisbury C., Sharp D., Thompson E., Peters T.J. Predictors of complementary therapy use among asthma patients: results of a primary care survey. Health Soc Care Community 2008 Mar; 16 (02) 155-164.
- 3 Spence D.S., Thompson E.A., Barron S.J. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005 Oct; 11 (05) 793-798.
- 4 Thompson E.A., Mathie R.T., Baitson E.S. et al. Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008 Jul; 97 (03) 114-121.
- 5 Thompson E.A., Dahr J., Susan M., Barron S. Setting standards in homeopathic practice – a pre-audit exploring motivation and expectation for patients attending the Bristol Homeopathic Hospital. Homeopathy 2007 Oct; 96 (04) 243-246.
- 6 Witt C.M., Bluth M., Albrecht H., Weisshuhn T.E., Baumgartner S., Willich S.N. The in vitro evidence for an effect of high homeopathic potencies – a systematic review of the literature. Complement Ther Med 2007 Jun; 15 (02) 128-138.
- 7 Gariboldi S., Palazzo M., Zanobbio L. et al. Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther 2009 Dec; 22 (06) 497-510.
- 8 McCarney R.W., Linde K., Lasserson T.J. Homeopathy for chronic asthma. Cochrane Database Syst Rev 2004 (01): CD000353.
- 9 Witt C.M., Ludtke R., Baur R., Willich S.N. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005 Nov 3; 5: 115.
- 10 Reilly D., Taylor M.A., Beattie N.G. et al. Is evidence for homoeopathy reproducible?. Lancet 1994 Dec 10; 344 (8937): 1601-1606.
- 11 Lewith G.T., Watkins A.D., Hyland M.E. et al. Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial. BMJ 2002 Mar 2; 324 (7336); 520.
- 12 White A., Slade P., Hunt C., Hart A., Ernst E. Individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003 Apr; 58 (04) 317-321.
- 13 Fisher P., Chatfield K., Mathie R. Homeopathy in childhood asthma. Thorax 2003 Sep; 58 (09) 827.
- 14 Levy M.L., Thomas M., Small I., Pearce L., Pinnock H., Stephenson P. Summary of the 2008 BTS/SIGN British Guideline on the management of asthma. Prim Care Respir J 2009 Jan; 18 (Suppl. 01) S1-S16.
- 15 Campbell N.C., Murray E., Darbyshire J. et al. Designing and evaluating complex interventions to improve health care. BMJ 2007 Mar 3; 334 (7591): 455-459.
- 16 British guideline on the management of asthma. Thorax 2003 Feb; 58 (Suppl. 01) i1-i94.
- 17 Juniper E.F. Assessing asthma control. Curr Allergy Asthma Rep 2007 Sep; 7 (05) 390-394.
- 18 Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996 Feb; 5 (01) 35-46.
- 19 Netten A., Curtis L. Unit costs of health and social care 2007. PSSRU University of Kent; 2008.
- 20 Department of Health. National tariff 2006/07. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4127649 2009 [cited 2009 May 6].
- 21 Department of Health. Reference cost index 2004. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4105545 2009 [cited 2009 May 6].
- 22 British National Formulary www.bnf.org/bnf/ 9 A.D. [cited 2009 May 6].
- 23 The Automobile Association. The AA schedule of motoring costs. http://www.theaa.com/motoring_advice/motoring_costs.htm 2009 [cited 2009 May 6].
- 24 Reilly D., Mercer S.W., Bikker A.P., Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007 Sep 2; 7: 139.
- 25 Hollinghurst S., Shaw A., Thompson E.A. Capturing the value of complementary and alternative medicine: including patient preferences in economic evaluation. Complement Ther Med 2008 Feb; 16 (01) 47-51.
- 26 Thompson E.A., Quinn T., Paterson C., Cooke H., McQuigan D., Butters G. Outcome measures for holistic, complex interventions within the palliative care setting. Complement Ther Clin Pract 2008 Feb; 14 (01) 25-32.
- 27 Rossi E., Crudeli L., Endrizzi C., Garibaldi D. Cost–benefit evaluation of homeopathic versus conventional therapy in respiratory diseases. Homeopathy 2009 Jan; 98 (01) 2-10.
- 28 Ernst E., Lee M.S. A trial design that generates only “positive” results. J Postgrad Med 2008 Jul; 54 (03) 214.
- 29 House of Commons. Science and technology committee – fourth report. Evidence check 2: homeopathy. www.publications.parliament.uk/pa/cm200910/cmselect/cmsctech/45/4502.htm February 2010 [accessed 04.04.2011].
- 30 Relton C., Smith C., Raw J. et al. Healthcare provided by a homeopath as an adjunct to usual care for Fibromyalgia (FMS): results of a pilot Randomised Controlled Trial. Homeopathy 2009 Apr; 98 (02) 77-82.
- 31 Witt C., Keil T., Selim D. et al. Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med 2005 Jun; 13 (02) 79-86.
- 32 Trichard M., Chaufferin G., Nicoloyannis N. Pharmacoeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children. Homeopathy 2005 Jan; 94 (01) 3-9.
- 33 Kneis K.C., Gandjour A. Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults. Appl Health Econ Health Policy 2009; 7 (03) 181-191.